Morgan Stanley sees Chewy positioned in the veterinary market, noting the company benefits from Trump-era tariffs and onshoring trends.
2 reports, 1 independent
Updated Jul 12
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley sees Chewy positioned in the veterinary market, noting the company benefits from Trump-era tariffs and onshoring trends.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Morgan Stanley named Chewy its top stock pick, citing that the company's existing health business generates over $3 billion in sales.Sub-event
Morgan Stanley sees Chewy positioned in the veterinary market, benefiting from Trump-era tariffs and onshoring.1 source
Keep exploring
The entities involved
-
Chewy
internet retailer of pet items
-
Morgan Stanley
U.S. investment bank
Related events
- Chewy and Petco presented to Goldman Sachs investors on September 23, 2026.
- Chewy supplies items across the United States.
- Both Chewy and General Mills report that consumer spending is shifting toward products catering to cats.
- The Iran war caused supply chain strains, leading to tariffs implemented by Donald Trump impacting trade with Iran, involving Morgan Stanley.
Coverage
Newest first; wire copies grouped- Insider MonkeyMorgan Stanley Bullish About Chewy (CHWY) Prospects in $40B Veterinary Clinic Market Chewy, Inc. (NYSE:CHWY) is one of the top e-commerce stocks with long-term potential. On June 24, Morgan Stanley r
- Unknown outlet